Literature DB >> 19530905

Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.

Alpesh Mistry1, Sys Zoffmann Glud, Jørgen Kjems, Jens Randel, Kenneth Alan Howard, Snjezana Stolnik, Lisbeth Illum.   

Abstract

Small molecular weight drugs, peptides, and nanoparticles have previously been shown to localize in the central nervous system after intraneural administration. A basic understanding of direct nose-to-brain drug delivery, particularly for nanoparticles with different physicochemical characteristics, remains unclear. In this study, fluorescence microscopy and stereology were used to track intranasally administered chitosan-coated polystyrene (C-PS) or polysorbate-coated polystyrene (P80-PS) nanoparticles (100 nm or 200 nm in diameter) in olfactory and respiratory nasal epithelia and olfactory bulbs in mice. Chitosan coating caused particles to adhere to the extracellular mucus which could provide useful modality for paracellular drug transport. Nanoparticle transport was exclusively transcellular. None of the nanoparticle formulations showed preference for uptake into olfactory axons over other nasal epithelial cells. Both 100 nm PS and 100 nm P80-PS were observed in olfactory epithelial cells but were absent from the olfactory bulbs; therefore, it is speculated that an optimal nanoparticle diameter for axonal transport is <100 nm in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19530905     DOI: 10.1080/10611860903055470

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  30 in total

Review 1.  Translocation of particles deposited in the respiratory system: a systematic review and statistical analysis.

Authors:  Hideo Nakane
Journal:  Environ Health Prev Med       Date:  2011-11-20       Impact factor: 3.674

2.  Pharmacokinetic evaluation of intranasally administered vinyl polymer-coated lorazepam microparticles in rabbits.

Authors:  Yanjun Zhao; Marc B Brown; Rajeshree H Khengar; Matthew J Traynor; Pedro Barata; Stuart A Jones
Journal:  AAPS J       Date:  2012-03-01       Impact factor: 4.009

3.  Nanomaterials in controlled drug release.

Authors:  Xin-Jun Cai; Ying-Ying Xu
Journal:  Cytotechnology       Date:  2011-07-01       Impact factor: 2.058

4.  Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats.

Authors:  Sravanthi Reddy Pailla; Sreekanth Talluri; Nagarjun Rangaraj; Ramdas Ramavath; Veerabhadra Swamy Challa; Nandkumar Doijad; Sunitha Sampathi
Journal:  Daru       Date:  2019-06-29       Impact factor: 3.117

Review 5.  Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS.

Authors:  Anupam Sarma; Malay K Das
Journal:  Mol Biomed       Date:  2020-12-10

6.  Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.

Authors:  Sara Hernando; Enara Herran; Joana Figueiro-Silva; José Luis Pedraz; Manoli Igartua; Eva Carro; Rosa Maria Hernandez
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

7.  Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.

Authors:  Anne-Claire Groo; Kristina Mircheva; Jérôme Bejaud; Caroline Ailhas; Ivan Panaiotov; Patrick Saulnier; Tzvetanka Ivanova; Frederic Lagarce
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

Review 8.  Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.

Authors:  Ashaben Patel; Mitesh Patel; Xiaoyan Yang; Ashim K Mitra
Journal:  Protein Pept Lett       Date:  2014       Impact factor: 1.890

9.  Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease.

Authors:  Richard McClure; Daijiro Yanagisawa; Donald Stec; Dave Abdollahian; Dmitry Koktysh; Dritan Xhillari; Rudolph Jaeger; Gregg Stanwood; Eduard Chekmenev; Ikuo Tooyama; John C Gore; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles.

Authors:  Sara Perteghella; Giovanna Rassu; Elisabetta Gavini; Antonella Obinu; Elia Bari; Delia Mandracchia; Maria Cristina Bonferoni; Paolo Giunchedi; Maria Luisa Torre
Journal:  Pharmaceutics       Date:  2021-05-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.